Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Rapivab (BioCryst Pharmaceuticals)
(https://rapivab.com) 📸 Data Snapshot: May 24, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Flu Antiviral | Rapivab (https://rapivab.com)
Flu Antiviral | Rapivab
NAV_HEADER_REPEATED Dosing and Administration | Rapivab (https://rapivab.com/dosing-and-administration/)
Dosing and Administration | Rapivab
NAV_HEADER_REPEATED How Supplied | Rapivab (https://rapivab.com/how-supplied/)
How Supplied | Rapivab
NAV_HEADER_REPEATED Coding and Billing | Rapivab (https://rapivab.com/coding-and-billing/)
Coding and Billing | Rapivab
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://rapivab.com) Flu Antiviral | Rapivab
[IMG: Rapivab] [H3] See what makes Rapivab stand out as an antiviral influenza treatment [H4] A FULL COURSE of ANTIVIRAL INFLUENZA TREATMENT IN [H4] SHORTENED TIMEto alleviation of symptoms by a median of [H5] In patients aged 6 months to 17 years, symptoms were resolved in a median of 79 hours vs. 100 hours for oseltamivir1 [H4] SHORTENED TIMEto resolution of fever by a median of [H5] In patients aged 6 months to 17 years, fever was resolved in a median of 40 hours vs. 35 hours for oseltamivir1,2 [H1] It’s easy to access and order Rapivab To order, please call 1-833-964-2956 if you are a US-based institution or health care professional. ORDER RAPIVAB References: 1. Rapivab [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc; 2021. 2. Kohno S, Kida H, Mizuguchi M, Shimada J; S-021812 Clinical Study Group. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010;54(11):4568-4574. 3. BioCryst Pharmaceuticals, Inc. Summary of clinical efficacy. Data on file. 4. Managed Markets Insights & Technology, LLC website. https://formularylookup.com/. Accessed March 16, 2021.
SUB-PAGE (https://rapivab.com/dosing-and-administration/) Dosing and Administration | Rapivab
[H1] Dosing & Administration [H3] One 15- to 30-minute intravenous (IV) infusion provides a full course of antiviral influenza treatment1 Use these dosing guidelines to determine the dosage of Rapivab® (peramivir injection) for your patients 6 months of age and older. The administration of Rapivab in patients with renal impairment is at the discretion of the treating physician. [H3] Preparation of Rapivab for IV infusion Use aseptic technique during the preparation of Rapivab to prevent inadvertent microbial contamination. There is no preservative or bacteriostatic agent present in the solution.1 [H4] Follow the steps below to prepare a diluted solution of Rapivab1: 1. Do not use if seal over bottle opening is broken or missing. 2. Visually inspect Rapivab for particulate matter and discoloration prior to administration. 3. Dilute an appropriate dose of RAPIVAB 10 mg/mL solution [see Dosage and Administration (2.1, 2.2)] in 0.9% or 0.45% sodium chloride, 5% dextrose, or lactated Ringer’s. The maximum infusion volume is provided in Table 3. The final concentration of diluted RAPIVAB for administration should be between 1 mg/mL and 6 mg/mL. 4. Administer the diluted solution via intravenous infusion for 15 to 30 minutes. 5. Discard any unused diluted solution of Rapivab after 24 hours. Once a diluted solution of Rapivab has been prepared, administer immediately or store under refrigerated conditions (2° to 8°C or 36° to 46°F) for up to 24 hours. If refrigerated, allow the diluted solution of Rapivab to reach room temperature, then administer immediately. Do not use if seal over bottle opening is broken or missing. Reference: 1. Rapivab [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc; 2021.
SUB-PAGE · THIN (https://rapivab.com/how-supplied/) How Supplied | Rapivab
[H1] How Supplied [H3] Rapivab® (peramivir injection) is supplied in convenient single-use vials Each single-use vial of Rapivab contains 200 mg per 20 mL (10 mg/mL) of peramivir in a clear glass vial (NDC #72769-181-01).1 Rapivab is supplied in cartons containing 3 single-use vials (NDC #72769-181-03).1 Reference: 1. Rapivab [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc; 2021.
SUB-PAGE (https://rapivab.com/coding-and-billing/) Coding and Billing | Rapivab
[H1] Coding and Billing [H3] Coding and billing information for Rapivab® (peramivir injection) Use this information to facilitate coding and billing processes. Some payers will require the National Drug Code (NDC) code for Rapivab.1 [H3] Support and access for Rapivab [H4] RAPIVAB CUSTOMER SUPPORT CENTER 1-833-964-2956 and rapivab.com Current Procedural Terminology (CPT) Codes for Rapivab The following CPT codes are for treatments administered via injection to individuals. CPT Code 2 Description 96365 Intravenous (IV) infusion for therapy, prophylaxis, or diagnosis; initial, up to first hour 96366 IV med therapy−each additional hour 96374 IV med injection−first med 96375 IV med injection−second med subsequent injection 96376 IV med injection−first med subsequent injection 96360 IV hydration−first hour 96361 IV hydration−each additional hour HCPCS Code 3 Description J2547 Injection, peramivir, 1 mg Report the administration of Rapivab in addition to the treatment product code Assign the appropriate administration code based on the documentation in the medical record Medicare requires the use of an HCPCS code for the administration of Rapivab. Some payers may also require that an HCPCS code be used to report Rapivab Prior authorizations or appeals may not be completed or filed on the HCP's behalf. Revenue codes for Rapivab These codes are used to attribute hospital charges to specific cost centers. They may vary by service provided and patient status. Revenue Code 4 Description 0636 Drugs requiring detailed coding required by Medicare to obtain pass-through payment for drugs in the outpatient department 0250 Pharmacy, general 0260 Intravenous therapy, general 0450 Emergency room 0510 Clinic 0520 IV hydration–first hour ICD-10-CM codesa for Rapivab Refer to these tables when you need the ICD-10-CM codes for Rapivab. ICD-10 Code 5 Description J10.00 Influenza due to other identified influenza virus with unspecified type of pneumonia J10.01 Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia J10.08 Influenza due to other identified influenza virus with other specified pneumonia J11.00 Influenza due to unidentified influenza virus with unspecified type of pneumonia J11.08 Influenza due to unidentified influenza virus with specified pneumonia J12.9 Viral pneumonia, unspecified J10.1 Influenza due to other identified influenza virus with other respiratory manifestations J11.1 Influenza due to unidentified influenza virus with other respiratory manifestations J10.2 Influenza due to other identified influenza virus with gastrointestinal manifestations J10.81 Influenza due to other identified influenza virus with encephalopathy J10.82 Influenza due to other identified influenza virus with myocarditis J10.83 Influenza due to other identified influenza virus with otitis J10.89 Influenza due to other identified influenza virus with other manifestations J11.2 Influenza due to unidentified influenza virus with gastrointestinal manifestations J11.81 Influenza due to unidentified influenza virus with encephalopathy J11.82 Influenza due to unidentified influenza virus with myocarditis J11.83 Influenza due to unidentified influenza virus with otitis media J11.89 Influenza due to unidentified influenza virus with other manifestations J09.X1 Influenza due to identified novel influenza A virus with pneumonia J09.X2 Influenza due to identified novel influenza A virus with other respiratory manifestations J09.X3 Influenza due to identified novel influenza A virus with gastrointestinal manifestations J09.X9 Influenza due to identified novel influenza A virus with other manifestations aThis may not be an all-inclusive list; see payor-specific coverage policies for covered indication. References: 1. Rapivab [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc; 2021. 2. Current Procedural Coding Expert; 2021 Chicago IL: Optum360; 2021. 3. Parman C. Hospital regulatory update. Association of Community Cancer Centers website. https://www.accc-cancer.org/oncology_issues/articles/JF16/JF16-Oncology-Coding-Reimbursement-Update.pdf. Accessed March 16, 2021. 4. CMS Manual System: Pub. 100-04 Medicare claims processing. Centers for Medicare & Medicaid Services website. https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/r167cp.pdf. Published April 30, 2004. Accessed March 16, 2021. 5. Nelson M. ICD-10 cometh. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=0ahUKEwih4NKzjLfLAhXLTCYKHc2LAAUQFgg5MAQ&url=https%3A%2F%2Fwww.chestnet.org%2F~%2Fmedia%2Fchesnetorg%2FPublications%2FDocuments%2FCHEST%2520Physician%2FICD10InfluenzaCodes.ashx&usg=AFQjCNH5tCT-_gZ8SmRF_CZi0vB-OvUyFQ&sig2=JQocAaPEHmQ0wQsagrgHLQ&bvm=bv.116573086,d.cWw. Published April 2015. Accessed March 16, 2021.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /dosing-and-administration/ | 0 | 0 |
| /how-supplied/ | 0 | 0 |
| /coding-and-billing/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Rapivab (BioCryst Pharmaceuticals) (rapivab.com)
This is an exceptionally low-BS clinical resource that prioritizes technical utility for healthcare providers over marketing fluff. Its data-heavy approach to billing, dosing, and efficacy provides immediate substance that justifies its claims. The only significant detractors are the lack of modern structured data and the aging reference citations.
Implement MedicalEntity and Drug schema.org structured data to explicitly define the drug’s indication and dosage for search engines. Update the ‘Coding and Billing’ section to explicitly state it reflects current 2026 CMS guidelines, as the current 2021 references are temporally stale. Include a ‘Last Updated’ timestamp on clinical data to reassure HCPs of the medication’s current standing in the therapeutic area. Add direct, high-visibility links to the latest peer-reviewed real-world evidence (RWE) published between 2021 and 2026.
The website perfectly aligns with the Pharmaceutical and Biotech industry, specifically focusing on a prescribed antiviral medication. The content is heavily regulated, technical, and targeted toward healthcare professionals, evidenced by the inclusion of Important Safety Information and clinical dosing guidelines.
“The score of 7 is driven primarily by the site's technical staleness and lack of structured identity data (Pillar 5). It earned nearly perfect scores in Information Density and Trust and Proof due to its exhaustive use of NDCs, CPT codes, and clinical trial citations. The site represents the antithesis of 'Business BS,' serving as a functional tool rather than a promotional brochure.”
This training module utilizes a snapshot of public data from Rapivab (BioCryst Pharmaceuticals), captured on May 24, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Rapivab (BioCryst Pharmaceuticals): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rapivab.com to view the most current version of its content and learn from the source what this company is about and what it offers.